Back

How should we best optimise therapy for HFrEF?

29 August 2025 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: HFrEF treatment: where are we and where are we going? Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Mattia Arrigo

EOC Cantonal Hospital, Bellinzona (Switzerland)

4 More presentations in this session

Presentation thumbnail
What is current guideline-recommended medical therapy for HFrEF?
Professor J. Bauersachs (Hannover, DE)
Slides Video
Presentation thumbnail
When should we downtitrate or stop HFrEF therapy?
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
What is on the horizon for HFrEF therapy?
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
HFrEF treatment: where are we and where are we going? - discussion
Video

Access the full session

Session thumbnail
HFrEF treatment: where are we and where are we going?
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 08:33 CET
You may be interested in
thumbnail
Congress Session
Rapid optimisation of evidence-based treatment for heart failure with reduced ejection fraction: how to do it
27 August 2023
thumbnail
Congress Session
The practicalities of drug treatment in heart failure
28 August 2022
thumbnail
Congress Presentation
How to manage guideline-directed medical therapy around decongestion
10 May 2026
thumbnail
Congress Presentation
Implementing ESC 2021 Guideline-recommended HF care: where do we stand now?
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources